A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls

Serum biomarkers have not been fully incorporated into clinical use for the diagnosis of renal cell carcinoma (RCC). The recent discovery of long noncoding RNAs (lncRNAs), which have been reported in a variety of cancer types, suggested a promising new class of biomarkers for tumour diagnosis. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Y, Wang, Y-Q, Weng, W-W, Zhang, Q-Y, Yang, X-Q, Gan, H-L, Yang, Y-S, Zhang, P-P, Sun, M-H, Xu, M-D, Wang, C-F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154346/
https://www.ncbi.nlm.nih.gov/pubmed/26878386
http://dx.doi.org/10.1038/oncsis.2015.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154346/
https://www.ncbi.nlm.nih.gov/pubmed/26878386
http://dx.doi.org/10.1038/oncsis.2015.48

Ejemplares similares